INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2025

Cocoa extract supplementation did not reduce overall incident hypertension in older adults, though it lowered risk in those with baseline systolic BP <120 mm Hg.

In the COSMOS trial, 8,905 older adults free of baseline hypertension were randomized to daily cocoa extract (500 mg/d cocoa flavanols with 80 mg/d [-]-epicatechin) or placebo. Over a median follow-up of 3.4 years, cocoa extract did not significantly reduce incident hypertension overall (7.1 vs 7.4 per 100 person-years; HR 0.96 [95% CI, 0.88-1.05]). However, in subgroup analysis, cocoa extract reduced incident hypertension among participants with baseline systolic BP <120 mm Hg (HR 0.76 [95% CI, 0.64-0.90]), but not among those with baseline systolic BP of 120 to 139 mm Hg (HR 1.05 [95% CI, 0.93-1.18]; P-interaction=0.002).

Study type
2x2 factorial, double-blind, placebo-controlled randomized clinical trial
Who was studied
8,905 older adults (women aged >=65, men aged >=60) free from baseline hypertension (mean age 71.1 years, 59% women)
What was measured
Incident hypertension (self-reported physician diagnosis, medication initiation, or elevated blood pressure)

THE PAPER

Long-Term Effect of Cocoa Extract Supplementation on Incident Hypertension.

Hamaya R, Li S, Lau J, Allison M, Haring B, Shadyab AH, Matthew N, Martin LW, Rist PM, Manson JE, Sesso HD, COSMOS Research Group. Hypertension, 2025.

PubMed 40832703 ↗DOI 10.1161/hypertensionaha.125.25209 ↗

Heart & arteriesBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.